---
title: "3M: Competitors & Industry Structure"
description: "3M compared with companies that share its SEC industry classification: revenue, growth and margins from SEC filings, and how the peer group is chosen."
canonical: https://www.getswoopr.com/stocks/companies/3m/competitors/
source: "Swoopr Investment: https://www.getswoopr.com"
---

# 3M: Competitors & Industry Structure



## Direct Answer

SEC EDGAR classifies 3M under SIC code 3841 (Surgical & Medical Instruments & Apparatus). Among Swoopr's S&P 500 Equal Weight companies, 84 others share that classification; by latest reported revenue, 3M ranks 3 of 85. A filing classification is a starting point: a company's real competitors depend on its segments, which its 10-K describes.

## How Does 3M Compare With Its Peers?

| Company | Revenue (latest FY) | Revenue growth | Operating margin | Net margin |
| --- | --- | --- | --- | --- |
| [Medline Inc. (MDLN)](https://www.getswoopr.com/stocks/companies/medline-inc/) | $28.4 billion FY2025 | 11.5% | 7.8% | 4069.4% |
| [Stryker Corporation (SYK)](https://www.getswoopr.com/stocks/companies/stryker-corporation/) | $25.1 billion FY2025 | 11.2% | 19.5% | 12.9% |
| **3M (MMM)** | $24.9 billion FY2025 | 1.5% | 18.6% | 13.0% |
| [Becton Dickinson (BDX)](https://www.getswoopr.com/stocks/companies/becton-dickinson/) | $21.8 billion FY2025 | 8.2% | 11.8% | 7.7% |
| [Boston Scientific (BSX)](https://www.getswoopr.com/stocks/companies/boston-scientific/) | $20.1 billion FY2025 | 19.9% | 18.0% | 14.4% |
| [Baxter International (BAX)](https://www.getswoopr.com/stocks/companies/baxter-international/) | $11.2 billion FY2025 | 5.7% | -2.7% | -8.5% |
| [Solventum (SOLV)](https://www.getswoopr.com/stocks/companies/solventum/) | $8.3 billion FY2025 | 0.9% | 26.2% | 18.7% |
| [ResMed (RMD)](https://www.getswoopr.com/stocks/companies/resmed/) | $5.1 billion FY2025 | 9.8% | 32.7% | 27.2% |
| [Dexcom (DXCM)](https://www.getswoopr.com/stocks/companies/dexcom/) | $4.7 billion FY2025 | 15.6% | 19.6% | 17.9% |
| [MiniMed Group Inc. (MMED)](https://www.getswoopr.com/stocks/companies/minimed-group-inc/) | $3.1 billion FY2026 | 14.3% | -6.1% | -10.7% |
| [West Pharmaceutical Services (WST)](https://www.getswoopr.com/stocks/companies/west-pharmaceutical-services/) | $3.1 billion FY2025 | 6.3% | 19.0% | 16.1% |
| [Globus Medical Inc. (GMED)](https://www.getswoopr.com/stocks/companies/globus-medical-inc/) | $2.9 billion FY2025 | 16.7% | 16.3% | 18.3% |
| [Insulet Corporation (PODD)](https://www.getswoopr.com/stocks/companies/insulet-corporation/) | $2.7 billion FY2025 | 30.7% | 17.5% | 9.1% |
| [Penumbra Inc. (PEN)](https://www.getswoopr.com/stocks/companies/penumbra-inc/) | $1.4 billion FY2025 | 17.5% | 13.5% | 12.7% |
| [Haemonetics Corporation (HAE)](https://www.getswoopr.com/stocks/companies/haemonetics-corporation/) | $1.3 billion FY2026 | -2.0% | 11.7% | 0.0% |
| [Embecta Corp. (EMBC)](https://www.getswoopr.com/stocks/companies/embecta-corp/) | $1.1 billion FY2025 | -3.8% | 22.4% | 8.8% |
| [Alphatec Holdings Inc. (ATEC)](https://www.getswoopr.com/stocks/companies/alphatec-holdings-inc/) | $764 million FY2025 | 25.0% | -10.7% | -18.8% |
| [iRhythm Holdings Inc. (IRTC)](https://www.getswoopr.com/stocks/companies/irhythm-holdings-inc/) | $747 million FY2025 | 26.2% | -7.7% | -6.0% |
| [Bioventus Inc. (BVS)](https://www.getswoopr.com/stocks/companies/bioventus-inc/) | $568 million FY2025 | -0.9% | 9.5% | 4.0% |
| [AtriCure Inc. (ATRC)](https://www.getswoopr.com/stocks/companies/atricure-inc/) | $535 million FY2025 | 14.9% | -1.8% | -2.1% |
| [Accuray Incorporated (ARAY)](https://www.getswoopr.com/stocks/companies/accuray-incorporated/) | $459 million FY2025 | 2.7% | 1.7% | -0.3% |
| [MiMedx Group Inc (MDXG)](https://www.getswoopr.com/stocks/companies/mimedx-group-inc/) | $419 million FY2025 | 20.0% | 15.3% | 11.6% |
| [Tactile Systems Technology Inc. (TCMD)](https://www.getswoopr.com/stocks/companies/tactile-systems-technology-inc/) | $330 million FY2025 | 12.5% | 8.9% | 5.8% |
| [AngioDynamics Inc. (ANGO)](https://www.getswoopr.com/stocks/companies/angiodynamics-inc/) | $320 million FY2026 | 9.5% | -12.5% | -11.5% |
| [PROCEPT BioRobotics Corporation (PRCT)](https://www.getswoopr.com/stocks/companies/procept-biorobotics-corporation/) | $308 million FY2025 | 37.2% | -33.7% | -0.0% |
| [SkinHealth Systems Inc. (SKIN)](https://www.getswoopr.com/stocks/companies/skinhealth-systems-inc/) | $301 million FY2025 | -10.0% | -6.9% | -3.2% |
| [OrthoPediatrics Corp. (KIDS)](https://www.getswoopr.com/stocks/companies/orthopediatrics-corp/) | $236 million FY2025 | 15.4% | -16.6% | -16.8% |
| [Cerus Corporation (CERS)](https://www.getswoopr.com/stocks/companies/cerus-corporation/) | $234 million FY2025 | 16.1% | -3.7% | -6.7% |
| [Treace Medical Concepts Inc. (TMCI)](https://www.getswoopr.com/stocks/companies/treace-medical-concepts-inc/) | $213 million FY2025 | 1.6% | -25.5% | -27.7% |
| [SI-BONE Inc. (SIBN)](https://www.getswoopr.com/stocks/companies/si-bone-inc/) | $201 million FY2025 | 20.2% | -11.1% | -9.4% |
| [Heartflow Inc. (HTFL)](https://www.getswoopr.com/stocks/companies/heartflow-inc/) | $176 million FY2025 | 39.9% | -36.4% | -66.3% |
| [Neuronetics Inc. (STIM)](https://www.getswoopr.com/stocks/companies/neuronetics-inc/) | $149 million FY2025 | 99.2% | -21.1% | -26.1% |
| [InfuSystems Holdings Inc. (INFU)](https://www.getswoopr.com/stocks/companies/infusystems-holdings-inc/) | $143 million FY2025 | 6.4% | 8.3% | 4.6% |
| [Xtant Medical Holdings Inc. (XTNT)](https://www.getswoopr.com/stocks/companies/xtant-medical-holdings-inc/) | $134 million FY2025 | 14.2% | 5.4% | 0.0% |
| [OraSure Technologies Inc. (OSUR)](https://www.getswoopr.com/stocks/companies/orasure-technologies-inc/) | $115 million FY2025 | -38.1% | -62.6% | -59.8% |
| [Anika Therapeutics Inc. (ANIK)](https://www.getswoopr.com/stocks/companies/anika-therapeutics-inc/) | $113 million FY2025 | -5.9% | -9.8% | -9.8% |
| [Beta Bionics Inc. (BBNX)](https://www.getswoopr.com/stocks/companies/beta-bionics-inc/) | $100 million FY2025 | 53.9% | -71.5% | -73.0% |
| [Neuropace Inc. (NPCE)](https://www.getswoopr.com/stocks/companies/neuropace-inc/) | $100 million FY2025 | 25.1% | -16.3% | -21.5% |
| [Kestra Medical Technologies Ltd. (KMTS)](https://www.getswoopr.com/stocks/companies/kestra-medical-technologies-ltd/) | $95 million FY2026 | 59.0% | -141.6% | -138.4% |
| [Pulmonx Corporation (LUNG)](https://www.getswoopr.com/stocks/companies/pulmonx-corporation/) | $90 million FY2025 | 8.0% | -59.3% | -59.7% |
| [Delcath Systems Inc. (DCTH)](https://www.getswoopr.com/stocks/companies/delcath-systems-inc/) | $85 million FY2025 | 129.1% | 0.8% | 3.2% |
| [iRadimed Corporation (IRMD)](https://www.getswoopr.com/stocks/companies/iradimed-corporation/) | $84 million FY2025 | 14.4% | 31.2% | 26.8% |
| [TELA Bio Inc. (TELA)](https://www.getswoopr.com/stocks/companies/tela-bio-inc/) | $80 million FY2025 | 15.8% | -42.0% | -48.3% |
| [Sight Sciences Inc. (SGHT)](https://www.getswoopr.com/stocks/companies/sight-sciences-inc/) | $77 million FY2025 | -3.1% | -48.0% | -49.7% |
| [Avita Medical Inc. (RCEL)](https://www.getswoopr.com/stocks/companies/avita-medical-inc/) | $72 million FY2025 | 11.5% | -59.4% | -67.8% |
| [Pro-Dex Inc. (PDEX)](https://www.getswoopr.com/stocks/companies/pro-dex-inc/) | $67 million FY2025 | 23.7% | 16.1% | 13.5% |
| [LENSAR Inc. (LNSR)](https://www.getswoopr.com/stocks/companies/lensar-inc/) | $58 million FY2025 | 9.2% | -42.1% | -58.7% |
| [CVRx Inc. (CVRX)](https://www.getswoopr.com/stocks/companies/cvrx-inc/) | $57 million FY2025 | 10.4% | -90.5% | -94.1% |
| [Apyx Medical Corporation (APYX)](https://www.getswoopr.com/stocks/companies/apyx-medical-corporation/) | $53 million FY2025 | 9.9% | -12.2% | -21.2% |
| [Carlsmed Inc. (CARL)](https://www.getswoopr.com/stocks/companies/carlsmed-inc/) | $51 million FY2025 | 85.9% | -60.5% | -58.7% |
| [Shoulder Innovations Inc. (SI)](https://www.getswoopr.com/stocks/companies/shoulder-innovations-inc/) | $47 million FY2025 | 49.6% | -55.6% | -85.3% |
| [TriSalus Life Sciences Inc. (TLSI)](https://www.getswoopr.com/stocks/companies/trisalus-life-sciences-inc/) | $45 million FY2025 | 53.4% | -59.7% | -86.9% |
| [SANUWAVE Health Inc. (SNWV)](https://www.getswoopr.com/stocks/companies/sanuwave-health-inc/) | $44 million FY2025 | 35.0% | 11.2% | 26.8% |
| [KORU Medical Systems Inc. (KRMD)](https://www.getswoopr.com/stocks/companies/koru-medical-systems-inc/) | $41 million FY2025 | 22.2% | -7.2% | -6.4% |
| [Utah Medical Products Inc. (UTMD)](https://www.getswoopr.com/stocks/companies/utah-medical-products-inc/) | $39 million FY2025 | -5.8% | 29.6% | 29.3% |
| [Retractable Technologies Inc. (RVP)](https://www.getswoopr.com/stocks/companies/retractable-technologies-inc/) | $38 million FY2025 | 15.8% | -55.3% | -32.8% |
| [Cytosorbents Corporation (CTSO)](https://www.getswoopr.com/stocks/companies/cytosorbents-corporation/) | $37 million FY2025 | 4.1% | -39.8% | -22.1% |
| [ClearPoint Neuro Inc. (CLPT)](https://www.getswoopr.com/stocks/companies/clearpoint-neuro-inc/) | $37 million FY2025 | 17.8% | -65.4% | -69.1% |
| [Orchestra BioMed Holdings Inc. (OBIO)](https://www.getswoopr.com/stocks/companies/orchestra-biomed-holdings-inc/) | $33 million FY2025 | 1169.2% | -154.7% | -157.4% |
| [Sensus Healthcare Inc. (SRTS)](https://www.getswoopr.com/stocks/companies/sensus-healthcare-inc/) | $27 million FY2025 | -34.3% | -37.5% | -28.1% |
| [Spectral AI Inc. (MDAI)](https://www.getswoopr.com/stocks/companies/spectral-ai-inc/) | $20 million FY2025 | -33.6% | -43.8% | -38.5% |
| [Sonoma Pharmaceuticals Inc. (SNOA)](https://www.getswoopr.com/stocks/companies/sonoma-pharmaceuticals-inc/) | $20 million FY2026 | 36.7% | -12.6% | 0.0% |
| [Nephros Inc. (NEPH)](https://www.getswoopr.com/stocks/companies/nephros-inc/) | $19 million FY2025 | 32.7% | 6.1% | 6.4% |
| [Vivos Therapeutics Inc. (VVOS)](https://www.getswoopr.com/stocks/companies/vivos-therapeutics-inc/) | $17 million FY2025 | 16.0% | -114.1% | -121.4% |
| [NexGel Inc (NXGL)](https://www.getswoopr.com/stocks/companies/nexgel-inc/) | $11 million FY2025 | 31.5% | -29.3% | -26.3% |
| [NeuroOne Medical Technologies Corporation (NMTC)](https://www.getswoopr.com/stocks/companies/neuroone-medical-technologies-corporation/) | $9 million FY2025 | 163.5% | -46.5% | -39.6% |
| [Beyond Air Inc. (XAIR)](https://www.getswoopr.com/stocks/companies/beyond-air-inc/) | $8 million FY2026 | 107.3% | -378.2% | -433.0% |
| [INVO Fertility Inc. (IVF)](https://www.getswoopr.com/stocks/companies/invo-fertility-inc/) | $7 million FY2025 | 4.7% | -105.8% | 340.9% |
| [Cerenome Inc. (CNSY)](https://www.getswoopr.com/stocks/companies/cerenome-inc/) | $5 million FY2025 | -10.5% | -293.5% | -429.4% |
| [Lucid Diagnostics Inc. (LUCD)](https://www.getswoopr.com/stocks/companies/lucid-diagnostics-inc/) | $5 million FY2025 | 8.3% | -1054.8% | -1232.7% |
| [Tenon Medical Inc. (TNON)](https://www.getswoopr.com/stocks/companies/tenon-medical-inc/) | $4 million FY2025 | 20.4% | -324.3% | -318.4% |
| [Intelligent Bio Solutions Inc. (INBS)](https://www.getswoopr.com/stocks/companies/intelligent-bio-solutions-inc/) | $3 million FY2025 | -1.9% | -349.8% | -346.2% |
| [Femasys Inc. (FEMY)](https://www.getswoopr.com/stocks/companies/femasys-inc/) | $2 million FY2025 | 40.8% | -767.0% | -812.3% |
| [SeaStar Medical Holding Corporation (ICU)](https://www.getswoopr.com/stocks/companies/seastar-medical-holding-corporation/) | $1 million FY2025 | 814.1% | -986.6% | -984.6% |
| [RenovoRx Inc. (RNXT)](https://www.getswoopr.com/stocks/companies/renovorx-inc/) | $1 million FY2025 | 2511.6% | -1114.0% | -994.5% |
| [SiNtx Technologies Inc. (SINT)](https://www.getswoopr.com/stocks/companies/sintx-technologies-inc/) | $1 million FY2025 | -64.7% | -1053.1% | -1018.1% |
| [Co-Diagnostics Inc. (CODX)](https://www.getswoopr.com/stocks/companies/co-diagnostics-inc/) | $622,489 FY2025 | -84.1% | -8058.8% | -7550.3% |
| [Pulse Biosciences Inc (PLSE)](https://www.getswoopr.com/stocks/companies/pulse-biosciences-inc/) | $350,000 FY2025 | n/a | -21982.6% | -20794.6% |
| [Bluejay Diagnostics Inc. (BJDX)](https://www.getswoopr.com/stocks/companies/bluejay-diagnostics-inc/) | $249,040 FY2022 | n/a | -3741.5% | -3733.1% |
| [Profusa Inc. (PFSA)](https://www.getswoopr.com/stocks/companies/profusa-inc/) | $100,000 FY2024 | n/a | -4500.0% | -9230.0% |
| [PAVmed Inc. (PAVM)](https://www.getswoopr.com/stocks/companies/pavmed-inc/) | $71,000 FY2025 | -97.6% | -30712.7% | -5315.5% |
| [Adagio Medical Holdings Inc (ADGM)](https://www.getswoopr.com/stocks/companies/adagio-medical-holdings-inc/) | $0 FY2025 | n/a | n/a | n/a |
| [Aethlon Medical Inc. (AEMD)](https://www.getswoopr.com/stocks/companies/aethlon-medical-inc/) | $0 FY2024 | -100.0% | n/a | n/a |
| [Autonomix Medical Inc. (AMIX)](https://www.getswoopr.com/stocks/companies/autonomix-medical-inc/) | $0 FY2026 | n/a | n/a | n/a |
| [Fractyl Health Inc. (GUTS)](https://www.getswoopr.com/stocks/companies/fractyl-health-inc/) | $0 FY2025 | -100.0% | n/a | n/a |

Revenue growth compares each company's latest fiscal year with the one before. Fiscal years do not always end on the same date, so treat close comparisons with care.

![Bar chart of operating margin for 3M and 7 peers: Medline Inc. (MDLN) 7.8%, Stryker Corporation (SYK) 19.5%, 3M (MMM) 18.6%, Becton Dickinson (BDX) 11.8%, Boston Scientific (BSX) 18.0%, Baxter International (BAX) -2.7%, Solventum (SOLV) 26.2%, ResMed (RMD) 32.7%.](https://www.getswoopr.com/images/charts/3m-competitors-peer-margins.webp)
*Operating margin of 3M against companies sharing its SEC industry classification, from the table above. Select the chart to open it full size.*

## How Does 3M Rank Among All SEC Filers in Its Industry Code?

81 companies with annual reports in Swoopr's SEC dataset share SIC code 3841 (Surgical & Medical Instruments & Apparatus), a wider group than the S&P 500 Equal Weight companies above. Ranks run from 1 (highest) and use each company's latest fiscal year, in U.S. dollars.

| Measure | 3M | Median of filers | Rank |
| --- | --- | --- | --- |
| Revenue | $24.9 billion | $85 million | 3 of 81 |
| Revenue growth | 1.5% | 14.7% | 62 of 78 |
| Operating margin | 18.6% | -16.6% | 9 of 81 |
| Net margin | 13.0% | -18.8% | 13 of 81 |

A SIC code reflects the filer's main business as the SEC records it, so the group mixes companies of very different size; the median is a better guide than the average, and a rank near the top by revenue says nothing about quality.

## Where These Numbers Come From

Every figure on this page is a value 3M reported in its own SEC filings, read from the SEC's XBRL data (accession 0000066740-26-000014 for fiscal year 2025). Ratios are computed from those reported values. Figures were retrieved on October 7, 2026; a later amendment or a new annual report can change them, and the filing itself always takes precedence over this summary.

Each fiscal year is labeled by the calendar year in which it ended, so a company that names the same period differently in its own filings (many retailers whose year ends in January) may use another label. A year is left out of the table when the SEC data set holds no value for it. A figure shown as "Not reported" means the company did not file a value under the standard tag Swoopr reads, not that the amount was zero. This page is educational and describes reported history only; it is not a forecast or a recommendation.

## Frequently Asked Questions

### Who are 3M's competitors?

Companies sharing 3M's SEC classification (SIC code 3841 (Surgical & Medical Instruments & Apparatus)) include Medline Inc. (MDLN), Stryker Corporation (SYK), Becton Dickinson (BDX), Boston Scientific (BSX), Baxter International (BAX). Its 10-K names the competitors it considers most relevant.

### How does 3M compare with its peers on margins?

3M's fiscal 2025 operating margin was 18.6%, against a peer median of -18.8%.

### How are these peers chosen?

By the SEC Standard Industrial Classification code each company files under, within Swoopr's S&P 500 Equal Weight company set, falling back to the two-digit major group when fewer than two companies share the exact code. Classification codes are broad, so read the peer list as a screen, not a verdict.

### How does 3M rank among all companies in its SEC industry?

Among 81 SEC filers under SIC code 3841, 3M ranks 3 by latest revenue, and 9 of 81 by operating margin (18.6% against a median of -16.6%).

## References

- [SEC EDGAR: 3M CO Form 10-K filed February 3, 2026](https://www.sec.gov/Archives/edgar/data/66740/000006674026000014/mmm-20251231.htm)
- [SEC EDGAR: 3M CO annual and quarterly filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=66740&type=10-K)
- [SEC: EDGAR application programming interfaces (XBRL frames and submissions data)](https://www.sec.gov/search-filings/edgar-application-programming-interfaces)

## Related Pages

- [3M company dossier](https://www.getswoopr.com/stocks/companies/3m/)
- [3M financial metrics](https://www.getswoopr.com/stocks/companies/3m/metrics/)
- [3M financial risk indicators](https://www.getswoopr.com/stocks/companies/3m/risks/)
- [3M peer comparison](https://www.getswoopr.com/stocks/companies/3m/competitors/)
- [3M business model and revenue mix](https://www.getswoopr.com/stocks/companies/3m/business-model/)
- [Fundamental analysis guides](https://www.getswoopr.com/learn/fundamental-analysis/)





**[Swoopr Editorial Team](https://www.getswoopr.com/authors/swoopr-editorial-team/)**



Swoopr's editorial team produces independent investment education content reviewed for accuracy and clarity. We do not provide personalized financial advice. See our [editorial policy](https://www.getswoopr.com/legal/editorial-policy/) and [corrections policy](https://www.getswoopr.com/legal/corrections-policy/).